ALLMedicine™ Direct Antiglobulin Test Center
Research & Reviews 167 results
https://doi.org/10.1080/1744666X.2022.2089115
Expert Review of Clinical Immunology; Fattizzo B, Barcellini W
Jun 16th, 2022 - Autoimmune hemolytic anemia (AIHA) is classified according to the direct antiglobulin test (DAT) and thermal characteristics of the autoantibody into warm and cold forms, and in primary versus secondary depending on the presence of associated cond...
https://doi.org/10.1136/bcr-2021-248339
BMJ Case Reports; Yohannan B, Chan KH et. al.
May 24th, 2022 - Warm autoimmune haemolytic anaemia mediated by warm agglutinins is a rare and heterogeneous disease which can be idiopathic or secondary to an underlying disease. Primary sclerosing cholangitis is a chronic autoimmune cholangiopathy that is very r...
https://doi.org/10.7861/clinmed.2022-0142
Clinical Medicine (London, England); Palmer D, Seviar D
May 19th, 2022 - Haemolytic anaemia can seem like a complicated topic. The constellation of reticulocytosis, increased lactate dehydrogenase levels, increased unconjugated bilirubin levels and decreased haptoglobin levels should prompt general physicians to consid...
https://doi.org/10.1007/s10637-022-01254-2 10.1136/jitc-2020-SITC2020.0804 10.1007/s00277-021-04690-x 10.1038/clpt.1981.154 10.3389/fimmu.2020.01088 10.1053/j.seminhematol.2015.05.001 10.1111/ejh.13187
Investigational New Drugs; Tao Y, Han J et. al.
May 4th, 2022 - In August 2021, penpulimab, an anti-programmed cell death 1 (PD-1) monoclonal antibody, was approved in China for the treatment of adult patients with relapsed or refractory classic Hodgkin's lymphoma who completed at least second-line chemotherap...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9058691
BMJ Case Reports; Dawudi Y, Federici L et. al.
Apr 30th, 2022 - Impaired immune response with uncontrolled inflammation and various immunological disorders have been reported during SARS-CoV-2 infection. Here, we report a case of cold agglutinin disease occurring during a severe coronavirus disease 2019 (COVID...
Drugs 1 results see all →
Clinicaltrials.gov 4 results
https://clinicaltrials.gov/ct2/show/NCT02361788
Sep 2nd, 2020 - PROCEDURES DURING PREGNANCY During the first antenatal care visit the mother will have a gestational dating ultrasound to determine the accurate gestational age. During all antenatal care visits information about the mother will be collected as pa...
https://clinicaltrials.gov/ct2/show/NCT03827603
Jan 10th, 2020 - Subjects will give informed consent before any protocol specific assessments. Blood samples, physical examination, CT scan and bone marrow examination will be performed to determine baseline disease status and study eligibility. All examinations m...
https://clinicaltrials.gov/ct2/show/NCT03056378
Dec 26th, 2019 - This research study is enrolling subjects who are receiving RBC (red blood cell) blood transfusions as part of their treatment. In this study, we are testing a new way of preparing RBC units (pooled RBC units) for transfusion compared to the stand...
https://clinicaltrials.gov/ct2/show/NCT04024202
Jul 19th, 2019 - In autoimmune hemolytic anemia (AIHA) auto-antibodies directed against red blood cells (RBCs) lead to increased RBC clearance (hemolysis). This can result in a potentially life-threatening anemia. AIHA is a rare disease with an incidence of 1-3 pe...
News 10 results
https://www.mdedge.com/dermatology/article/202797/autoimmune-diseases/bullous-systemic-lupus-erythematosus-successfully
Christopher D. Lowe, MD, Catherine A. Brahe, MD et. al.
Jun 12th, 2019 - Bullous systemic lupus erythematosus (BSLE) is a rare cutaneous presentation of systemic lupus erythematosus (SLE). 1 Although 59% to 85% of SLE patients develop skin-related symptoms, fewer than 5% of SLE patients develop BSLE.
https://www.mdedge.com/hematologynews/nhlhub/article/184458/cll/consider-treatment-testing-when-cll-symptoms-emerge
Sharon Worcester
Nov 13th, 2018 - CHICAGO – Asymptomatic chronic lymphocytic leukemia (CLL) patients should be observed, but consider therapy when symptoms develop, said Paul M. Barr, MD.
https://www.mdedge.com/hematology-oncology/article/184400/transfusion-medicine/fda-clears-new-blood-typing-screening
Jennifer Smith
Nov 13th, 2018 - The Food and Drug Administration has granted marketing clearance for the immunohematology instrument NEO Iris. NEO Iris is a fully automated blood bank instrument designed for the mid- to high-volume laboratory, according to Immucor, the company m.
https://www.mdedge.com/hematology-oncology/article/154591/patient-survivor-care/cold-hemolytic-anemia-rare-complication
Exler et al
Dec 15th, 2017 - Autoimmune hemolytic anemia (AIHA) is characterized by the temperature at which the auto-antibody has the greatest avidity for the target red cell antigen, either warm or cold forms. It is detected by a positive direct antiglobulin test (DAT) also.
https://www.staging.medscape.com/viewarticle/739442
Mar 28th, 2011 - Clinical History A 60-year-old man undergoing chemotherapy for acute myelogenous leukemia was receiving a red blood cell (RBC) transfusion because his hemoglobin had dropped to 7.5 g/dL. He had received 6 units of RBCs and 3 units of platelets dur...